Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9186392 Combination therapy

Patent 9186392 was granted and assigned to Boehringer Ingelheim on November, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Boehringer Ingelheim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 17, 2015

Patent Application Number

13695492

Date Filed

May 5, 2011

Patent Citations Received

US Patent 11919903 Polymorphs

0

US Patent 11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

0

US Patent 11911387 Vasoprotective and cardioprotective antidiabetic therapy

0

US Patent 11911445 Peptide YY pharmaceutical formulations, compositions, and methods

0

US Patent 11759503 Compositions of GLP-1 peptides and preparation thereof

US Patent 11759502 Compositions of GLP-1 peptides and preparation thereof

US Patent 11759501 Compositions of GLP-1 peptides and preparation thereof

US Patent 11833248 Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid

0

Patent Primary Examiner

Patent abstract

The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9186392 Combination therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.